Biotechnology & Life Sciences Global On demand · 24-48h

Global Long Read Sequencing Market Strategic Research Report

Global Long Read Sequencing Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Long Read Sequencing Market
$2.44B2025
9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Consumables, Instruments, Services

By Application: Human Genetics and Biomedicine, Microbiology and Infectious Disease, Plant and Animal Sciences, Functional Genomics and Transcriptomics, Population and Evolutionary Genomics

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Oxford Nanopore Technologies, Pacific Biosciences of California, BaseClear B.V., Future Genomics Technologies, Garvan Institute of Medical Research, Genome Transcriptome Facility of Bordeaux, NextOmics, Takara Bio, Quantapore, Roche, MicrobesNG, Institute of Integrative Biology of the Cell

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 108 pages
Market size 2025
$2.44B
Billion USD
Forecast CAGR
9%
2025-2032
Forecast 2032
$4.5B
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Long Read Sequencing market size is predicted to grow from US$ 2,441 million in 2025 to US$ 4,472 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.

Long Read Sequencing (LRS) represents a paradigm shift in genomics, moving from reconstructing the genome like a puzzle to reading it in near-contiguous pieces. Unlike Short Read Sequencing (SRS), which fragments DNA into pieces 150-300 base pairs long (requiring complex computational assembly), LRS reads single molecules in lengths of 10,000 to over 1,000,000 base pairs.

Market Drivers

1. Structural Variant (SV) Resolution (Clinical Driver)

Context: Short reads detect SNPs (single nucleotide variants) well. They miss 50-70% of structural variants (deletions, insertions, inversions, duplications >50bp).

Clinical Implication: SVs are implicated in autism, schizophrenia, epilepsy, cancer, and developmental disorders.

Driver: LRS detects SVs directly. No inference. The variant is seen in the read alignment.

Market Signal: Major medical centers (Mayo Clinic, Rady Children's, Broad) transitioning rare disease diagnostics to LRS.

2. Phasing & Haplotype Resolution (Mendelian Genetics)

The Problem: Humans are diploid. Short reads mix maternal and paternal alleles.

The Consequence: Cannot determine if two mutations are on the same chromosome (cis) or opposite (trans). Critical for recessive disease carrier status.

The Solution: Long reads span both variants. Native phasing.

Driver: Reproductive genetics. Carrier screening accuracy improvement.

This report presents a comprehensive overview of the global Long Read Sequencing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Consumables
  • Instruments
  • Services

Segment by Technology

  • PacBio (Single Molecule Real-Time; SMRT Sequencing)
  • Oxford Nanopore Technologies (ONT)
  • Emerging and Hybrid Technologies

Segment by Application

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other

Segment by Application

  • Human Genetics and Biomedicine
  • Microbiology and Infectious Disease
  • Plant and Animal Sciences
  • Functional Genomics and Transcriptomics
  • Population and Evolutionary Genomics

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Long Read Sequencing market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Human Genetics and Biomedicine, Microbiology and Infectious Disease, Plant and Animal Sciences evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Long Read Sequencing Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.44B
2025
Forecast
$4.5B
2032
CAGR
9%
2025–2032
Regiones
5
global
Key companies
Oxford Nanopore TechnologiesPacific Biosciences of CaliforniaBaseClear B.V.Future Genomics TechnologiesGarvan Institute of Medical ResearchGenome Transcriptome Facility of BordeauxNextOmicsTakara Bio
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
ConsumablesInstrumentsServices
By Application
Human Genetics and BiomedicineMicrobiology and Infectious DiseasePlant and Animal SciencesFunctional Genomics and TranscriptomicsPopulation and Evolutionary Genomics

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Consumables
  • 3.1.3 Instruments
  • 3.1.4 Services
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Human Genetics and Biomedicine
  • 4.1.3 Microbiology and Infectious Disease
  • 4.1.4 Plant and Animal Sciences
  • 4.1.5 Functional Genomics and Transcriptomics
  • 4.1.6 Population and Evolutionary Genomics
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Oxford Nanopore Technologies
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Pacific Biosciences of California
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 BaseClear B.V.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Future Genomics Technologies
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Garvan Institute of Medical Research
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Genome Transcriptome Facility of Bordeaux
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 NextOmics
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Takara Bio
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Quantapore
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Roche
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 MicrobesNG
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Institute of Integrative Biology of the Cell
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Long Read Sequencing market?
The global Long Read Sequencing market is estimated at US$ 2.44 billion in 2025 (base year) and is projected to reach US$ 4.47 billion by 2032.
What is the forecast CAGR for the Long Read Sequencing market?
The market is expected to grow at a CAGR of 9.0% from 2026 to 2032, expanding from US$ 2.44 billion in 2025 to US$ 4.47 billion in 2032, roughly 1.8 times its base-year value.
What is Long Read Sequencing?
Long Read Sequencing (LRS) represents a paradigm shift in genomics, moving from reconstructing the genome like a puzzle to reading it in near-contiguous pieces. Unlike Short Read Sequencing (SRS), which fragments DNA into pieces 150-300 base pairs long (requiring complex computational assembly), LRS reads single molecules in lengths of 10,000 to over 1,000,000 base pairs.
What are the main segments of the Long Read Sequencing market by type?
By type, the market is segmented into Consumables, Instruments and Services.
Which applications drive demand in the Long Read Sequencing market?
Key applications covered include Human Genetics and Biomedicine, Microbiology and Infectious Disease, Plant and Animal Sciences, Functional Genomics and Transcriptomics and Population and Evolutionary Genomics.
Who are the key players in the Long Read Sequencing market?
Key players profiled include Oxford Nanopore Technologies, Pacific Biosciences of California, BaseClear B.V., Future Genomics Technologies, Garvan Institute of Medical Research, Genome Transcriptome Facility of Bordeaux, NextOmics and Takara Bio, among 12 companies covered in total.
Which regions and countries are covered for Long Read Sequencing?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Long Read Sequencing market report?
The report is intended for manufacturers and solution providers, distributors and end users in Human Genetics and Biomedicine, Microbiology and Infectious Disease and Plant and Animal Sciences, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Long Read Sequencing market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.